Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • johnson and johnson

    Tag: johnson and johnson

    You Searched For "johnson and johnson"
    Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development

    Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development

    Medical Dialogues Bureau14 March 2020 4:00 AM
    Janssen's vaccine program will use the Janssen AdVac® and PER.C6® technologies that provide the ability to rapidly upscale production of an optimal...
    HC relief  to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering

    HC relief to J&J: stays order directing co to pay Rs 230 crore on account of GST profiteering

    Medical Dialogues Bureau5 March 2020 7:15 AM
    It also said that prima facie the methodology used by NAPA to arrive at its finding of profiteering was "flawed".
    JnJ Faulty Hip Implants: 171 patients received compensation, says Ashwini Kumar Choubey

    JnJ Faulty Hip Implants: 171 patients received compensation, says Ashwini Kumar Choubey

    Medical Dialogues Bureau5 Feb 2020 9:45 AM
    "Based on the court order, a list of verified claimants along with supporting documents has been provided to Johnson and Johnson for complying with...
    Drugmajors slash prices by 53pc for China bulk-buy program eligibility

    Drugmajors slash prices by 53pc for China bulk-buy program eligibility

    Medical Dialogues Bureau20 Jan 2020 4:30 AM
    Beijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
    AstraZeneca leukemia drug Calquence gets USFDA okay

    AstraZeneca leukemia drug Calquence gets USFDA okay

    Medical Dialogues Bureau24 Nov 2019 4:30 AM
    New Delhi: AstraZeneca said late on Thursday that the U.S. Food and Drug Administration (FDA) had given its go-ahead for the company's Calquence drug...
    JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025

    JnJ enters series of new collaborations with Government, NGOs for ending TB in India by 2025

    Farhat Nasim31 Oct 2019 7:09 AM
    Hyderabad: Johnson & Johnson(JnJ) recently announced the expansion of its tuberculosis (TB) program in India in advance of the 50th Union World...
    New tests shows NO sign of asbestos in recalled JnJ baby powder

    New tests shows NO sign of asbestos in recalled JnJ baby powder

    Medical Dialogues Bureau30 Oct 2019 7:48 AM
    But Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Medical Dialogues Bureau9 Oct 2019 10:54 AM
    Johnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    Medical Dialogues Bureau7 Oct 2019 4:00 AM
    NEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
    22-member Committee Constituted to guide CDSCO on Medical Device Regulation

    22-member Committee Constituted to guide CDSCO on Medical Device Regulation

    Farhat Nasim27 July 2019 7:39 AM
    New Delhi: To advice the apex drug regulator, Central Drugs Standard Control Organisation (CDSCO) on matters related to the regulation and...
    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

    Farhat Nasim5 Jun 2019 4:30 AM
    Bosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    Meghna A Singhania3 April 2019 11:00 AM
    New Delhi: After facing trouble with its baby talcum powder amid allegations that it contains asbestos, US healthcare giant Johnson and Johnson (JnJ)...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok